It’s Getting Hot in Here: Sunshine Act Reporting Trends, Enforcement, and Best Practices

With a full year’s worth of Sunshine Act information and data reported to CMS, manufacturers and related stakeholders will face a number technical, regulatory, and legal challenges associated with the posting of this information by CMS on the Open Payments website in June 2015. As the government continues to push for increased transparency in many areas covering federal healthcare programs, increased attention and scrutiny may be given to Open Payments information by federal and state authorities, institutional employers, and private plaintiffs. Adding to this complexity are overlapping and additional requirements imposed on manufacturers by states, CIAs, and additional government authorities or associated entities. This webinar is designed to address these potential issues, including:

• Understanding the potential for CMS Enforcement, including auditing and inspection of manufacturers, as well as potential penalties
• Potential Fraud & Abuse implications and healthcare compliance risks associated with 2014 data posting
• Updates on Sunshine Act legislation, regulations, and guidance, including the impact on State transparency and gift ban laws
• Implications beyond Sunshine Act transparency — Medicare payment data, clinical trial transparency, CIA reporting, and institutional conflict of interest policies
• Best practices for 2015 and beyond

Date:

Monday, July 20, 2015
12:00 – 1:30 p.m. ET

Speakers:

• Abraham Gitterman, Associate, FDA and Healthcare Practice,
  Arnold & Porter LLP, Washington, DC
• Paul Silver, Managing Director, Practice Leader,
  Huron LifeSciences, Atlanta, GA